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Purpose: The aim of this study was to determine whether reclassifying the Fuhrman grading system provides further
prognostic information.
Materials and methods: We studied the pathological features and cancer specific survival of 237 patients with clear cell
cancer undergoing surgery between 1997–2007 in a single centre. The original Fuhrman grading system was investigated
as well as various simplified models utilising the original Fuhrman grade.
Results: The median follow up was 69 months. On univariate analysis, the conventional Fuhrman grading system as well
various simplified models were predicative of cancer specific survival. On multivariate analysis, only the three tiered
modified model in which grades 1 and 2 were combined whilst grades 3 and 4 were kept separate was an independent
predictor of cancer specific survival (p=0.001, HR 2.17, 95% CI 1.37-3.43). Furthermore this simplified model demonstrated
a stronger relationship to recurrence than the conventional 4 tiered Fuhrman grading system.
Conclusions: A modified, three-tiered Fuhrman grading system has been demonstrated to be an independent predictor
of cancer specific survival.
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In the UK alone, approximately 9000 new cases of renal
cancer are diagnosed each year and nearly 4000 die of
their disease (www.cancerresearchuk.org). Overall survival
is poor, even for those patients who undergo resection;
the estimated 5 year survival rate is only 50%.
Currently, the TNM stage and tumour grade are the
most widely used tools to predict survival. Various grading
classifications for clear cell carcinoma based on morpho-
logical features have been proposed (Arner et al. 1965;
Delahunt & Nacey 1987; Fuhrman et al. 1982; Lohse et al.
2002; Skinner et al. 1971; Syrjanen & Hjelt 1978; Thoenes
et al. 1986) and of these the Fuhrman grading system
(Fuhrman et al. 1982) has achieved widespread usage in
pathology practise. The Fuhrman grading system has been
demonstrated to be an independent predictor of survival
(Ficarra et al. 2001) having been acknowledged as optimal* Correspondence: tahir1@doctors.org.uk
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in any medium, provided the original work is pfor predicting outcome (Bostwick & Murphy 1998) and
therefore has been incorporated into the majority of prog-
nostic algorithms including Ssign (Frank et al. 2002), UISS
(Zisman et al. 2001) and Leibovich (Leibovich et al. 2003).
The Fuhrman grading system is based on assessment of
the uniformity of nuclear size, nuclear shape and nucleolar
prominence (Fuhrman et al. 1982). The Fuhrman grading
system has been demonstrated to correlate to metastasis
with grade 1 tumours having a statistically significant
lower metastases rate compared to those with grade 2 to 4
and survival rates being distinguished into 3 categories,
those with grade 1, those with grade 4 and those with
grades 2 and 3 (Fuhrman et al. 1982). Despite the popular-
ity of this grading system, problems have been demon-
strated regarding its application (Delahunt & Nacey 1987;
Delahunt 1998; Medeiros et al. 1997).
There has been suggestions that the Fuhrman grading
system has low-moderate inter-observer agreement
(Medeiros et al. 1997; Lang et al. 2005; Al-Aynati et al.
2003; Bektas et al. 2009) and that a simplified system
improves inter-observer agreement (Lang et al. 2005;an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Relationship between clinicopathological
characteristics and cancer specific survival
Variable Numbers
p-value
Age (<60/>60) 108/129 0.918
T Stage (1/2/3/4) 112/35/85/5 <0.001
Nuclear grade (1/2/3/4) 25/86/97/29 0.005
Recurrence (No/Yes) 178/59 <0.001
Table 2 Relationship between various simplified nuclear




























111/97/29 0.002 0.001 2.17 (1.37-3.43)
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accuracy as the conventional grading system (Sun et al.
2009; Rioux-Leclercq et al. 2007). Furthermore there are
those suggesting that the ideal grading system is yet to be
defined and should consist of three tiers (Medeiros et al.
1997) whilst a three tired system has been shown to be an
independent predictor of survival (Ficarra et al. 2005;
Hong et al. 2011). Given the evidence suggesting that a
simplified system improves the prognostic ability of the
Fuhrman grading, we aim to evaluate which if any simpli-
fied system would further aid in determining prognosis.
Materials and methods
Patients with clear cell renal cancer were included for this
study. These patients had undergone resection based on
the surgical findings and the results of CT scans for staging
purposes between January 1997 and Dec 2007 in the North
Glasgow NHS Trust. The Research Ethics Committee of
West of Scotland has approved the study.
Two hundred and thirty seven patients with clear cell
renal cancer were identified retrospectively that underwent
nephrectomy. The study cohort constituted a representative
sample of all surgically treated patients within this period.
Clinicopathological data including T stage, nuclear grade
assessment (Fuhrman et al. 1982) and survival for each
patient was collected. Survival was determined from the
time of surgical treatment to the time of last follow up.
The cause of death was determined by linkage through
the Scottish Cancer Registry. In those who were deceased,
if the primary cause of death was of renal cancer, these
were classed as cancer specific and all other causes were
non-cancer specific deaths. Patients notes were accessed
for documented evidence of recurrence otherwise they
were deemed to have no recurrences.
The original Fuhrman grading system was investigated as
well as various simplified systems utilising the Fuhrman
grade. Additional file 1 shows the various simplified models
that were investigated.
Statistical analysis was undertaken using SPSS (Chicago,
IL, USA). Cancer specific survival rates were generated
using the Kaplan Meir method. The log rank test was
utilised to compare significant differences between subset
groups using univariate analysis. Multivariate analysis was
carried out based on the results of the univariate analysis.
Multivariate Cox regression analysis was performed to
identify those factors that were independently associated
with cancer specific death. A stepwise backward procedure
was utilised to ascertain which of the variables had a signifi-
cant independent relationship with survival.
Results
The patient characteristics are shown in Table 1. The
median follow up was 69 (2.1-181) months. The median
age was 60 (23–86) years. Thirty three patients died of theirdisease. Within the cohort, the most common tumour stage
was pT1 (47%). The most common Fuhrman grades were
II (36%) and III (41%). Pathology slides were reviewed by a
single Uro-Pathologist.
Univariate analysis of potential predictors of cancer spe-
cific survival showed that the majority of the grading
models were statistically significant predictors of cancer
specific survival (Table 2, Figure 1). On multivariate analysis
of those that were significant on univariate, only model 5
which is a modified three tired model combining grades 1
and 2 whilst grades 3 and 4 are kept as separate was found
to be an independent prognostic factor in its association
with cancer specific survival (p=0.001, HR 2.17, 95% CI
1.37-3.43, Table 3).
On x2 analysis of the various simplified grading models,
whilst majority of the grading models demonstrated a posi-
tive correlation with T Stage (Table 3), model 3, which is a
two tired model combining grades 1, 2 and 3 whilst grade 4
is kept separate demonstrated the strongest correlation to
T Stage (p<0.001, Table 3). When analysing the grading
models, the majority of these demonstrated a positive cor-
relation to recurrence, whilst models 3 and 5 demonstrated
Figure 1 Kaplan Meier graphs demonstrating the conventional 4 tiered Fuhrman grading system (p=0.005) and a simplified model
where grades 1 and 2 are combined and grades 3 and 4 are kept separate (p=0.002) against disease specific survival.
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(p<0.001, Table 3).
Discussion
In this cohort of patients with clear cell carcinoma, a sim-
plified 3-tiered model where grades 1 and 2 are combined
whilst grades 3 and 4 were kept separate (model 5) was an
independent predictor of cancer specific survival on multi-
variate analysis. Furthermore, this modified model was also
one of only two to correlate to disease recurrence.
Several studies have demonstrated that the Fuhrman
grading system is capable of predicting cancer specific sur-
vival independent of pathological stage (Frank et al. 2002;
Patard et al. 2003). Studies however have demonstrated that
the conventional Fuhrman grading system is complex
(Ficarra et al. 2005; Medeiros et al. 1988) and that a simpli-
fied system improves inter-observer agreement (Lang et al.
2005; Al-Aynati et al. 2003). It has previously been demon-
strated that combining grades 1 and 2 improves the prog-
nostic ability of the Fuhrman grading system and a three
tiered system combining grades 1 and 2 whilst keeping
grades 3 and 4 separate is an independent predictor of sur-
vival (Ficarra et al. 2005; Hong et al. 2011), a finding similar
to that reported in this study. There has been reports thatTable 3 Interrelationship between clinicopathological
characteristics of patients and various simplified nuclear
grading systems
Variable Numbers T stage Recurrence
Nuclear grade (1/2/3/4) 25/86/97/29 0.001 0.001
Grading system 1 ((1+2)/(3+4)) 111/126 0.029 0.01
Grading system 2 ((1/(2+3+4)) 25/212 0.07 0.278
Grading system 3 ((1+2+3)/4) 208/29 <0.001 <0.001
Grading system 4 (1/2/(3+4)) 25/86/126 0.015 0.016
Grading system 5 ((1+2)/3/4) 111/97/29 0.001 <0.001this simplified three tiered model has a similar performance
in multivariate models predicting outcome to the conven-
tional 4 tiered Fuhrman system (Sun et al. 2009; Rioux-
Leclercq et al. 2007). In terms of cancer specific survival,
the gap between grades 3 and 4 was more evident than the
gap between grades 1 and 2. This result is similar to that
demonstrated by several other studies (Sun et al. 2009;
Rioux-Leclercq et al. 2007; Ficarra et al. 2005; Hong et al.
2011) where a three tiered model was proposed (Ficarra
et al. 2005; Hong et al. 2011). This further shows that
grades 3 and 4 would be less suitable for combining than
grades 1 and 2 and strengthens the argument for a three
tiered model.
As with most studies examining the modification of the
Fuhrman grading system, the present study is limited due
its retrospective nature with no analysis of inter or intra
observer variability when assigning the Fuhrman grade and
no external review of nuclear grade.
In the present study, a simplified version of the Fuhrman
grading system whereby grades 1 and 2 are combined and
grades 3 and 4 were kept separate was shown to be an
independent predictor of cancer specific survival and dem-
onstrated a positive correlation to disease recurrence
suggesting that this modified model can be considered an
option for the purposes of prognosis in those with clear cell
renal cancer. Further work is required in terms of a
prospective study for validation.Additional file
Additional file 1: Table S1. Demonstrating the various simplified
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